Activation of Free Fatty Acid Receptor 4 (FFA4) Ameliorates Ovalbumin-Induced Allergic Asthma by Suppressing Activation of Dendritic and Mast Cells in Mice

被引:17
|
作者
Son, So-Eun [1 ]
Koh, Jung-Min [2 ]
Im, Dong-Soon [1 ,3 ]
机构
[1] Kyung Hee Univ, Grad Sch, Dept Biomed & Pharmaceut Sci, Seoul 02447, South Korea
[2] Univ Ulsan, Div Endocrinol & Metab, Asan Med Ctr, Coll Med, Seoul 05505, South Korea
[3] Kyung Hee Univ, Grad Sch, Dept Basic Pharmaceut Sci, Seoul 02447, South Korea
基金
新加坡国家研究基金会;
关键词
allergy; asthma; free fatty acid receptor 4; FFA4; omega-3 polyunsaturated fatty acids; DAMPENS AIRWAY INFLAMMATION; DIETARY SUPPLEMENTATION; INSULIN-RESISTANCE; RESOLVIN E1; GPR120; OMEGA-3-FATTY-ACIDS; RESOLUTION; LIPIDS; MODEL;
D O I
10.3390/ijms23095270
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Epidemiological and clinical studies have suggested that intake of n-3 polyunsaturated fatty acids (PUFA) reduces the incidence of allergic airway diseases and improves pulmonary function in patients with allergic asthma. However, the pharmacological targets of PUFA have not been elucidated upon. We investigated whether free fatty acid receptor 4 (FFA4, also known as GPR120) is a molecular target for beneficial PUFA in asthma therapy. In an ovalbumin (OVA)-induced allergic asthma model, compound A (a selective agonist of FFA4) was administrated before OVA sensitization or OVA challenge in FFA4 wild-type (WT) and knock-out (KO) mice. Compound A treatment of RBL-2H3 cells suppressed mast cell degranulation in vitro in a concentration-dependent manner. Administration of compound A suppressed in vivo allergic characteristics in bronchoalveolar lavage fluid (BALF) and lungs, such as inflammatory cytokine levels and eosinophil accumulation in BALF, inflammation and mucin secretion in the lungs. Compound A-induced suppression was not only observed in mice treated with compound A before OVA challenge, but in mice treated before OVA sensitization as well, implying that compound A acts on mast cells as well as dendritic cells. Furthermore, this suppression by compound A was only observed in FFA4-WT mice and was absent in FFA4-KO mice, implying that compound A action is mediated through FFA4. Activation of FFA4 may be a therapeutic target of PUFA in allergic asthma by suppressing the activation of dendritic cells and mast cells, suggesting that highly potent specific agonists of FFA4 could be a novel therapy for allergic asthma.
引用
收藏
页数:15
相关论文
共 19 条
  • [1] Free fatty acid receptor 4 (FFA4) activation attenuates obese asthma by suppressing adiposity and resolving metaflammation
    Son, So-Eun
    Koh, Jung-Min
    Im, Dong-Soon
    BIOMEDICINE & PHARMACOTHERAPY, 2024, 174
  • [2] Free fatty acid receptor 4 (FFA4) activation ameliorates 2,4-dinitrochlorobenzene-induced atopic dermatitis by increasing regulatory T cells in mice
    Son, So-Eun
    Park, Soo-Jin
    Koh, Jung-Min
    Im, Dong-Soon
    ACTA PHARMACOLOGICA SINICA, 2020, 41 (10) : 1337 - 1347
  • [3] Pathophysiological regulation of lung function by the free fatty acid receptor FFA4
    Prihandoko, Rudi
    Kaur, Davinder
    Wiegman, Coen H.
    Alvarez-Curto, Elisa
    Donovan, Chantal
    Chachi, Latifa
    Ulven, Trond
    Tyas, Martha R.
    Euston, Eloise
    Dong, Zhaoyang
    Alharbi, Abdulrahman Ghali M.
    Kim, Richard Y.
    Lowe, Jack G.
    Hansbro, Philip M.
    Chung, Kian Fan
    Brightling, Christopher E.
    Milligan, Graeme
    Tobin, Andrew B.
    SCIENCE TRANSLATIONAL MEDICINE, 2020, 12 (557)
  • [4] Rubusoside alleviates the ovalbumin-induced mice allergic asthma by modulating the NF-κB activation
    Wang, Chengqiang
    Tang, Jia
    Qian, Bo
    Zeng, Zhen
    Gao, Yang
    Song, Jia-Le
    JOURNAL OF FOOD BIOCHEMISTRY, 2020, 44 (05)
  • [5] Free fatty acid receptor 4 activation protects against choroidal neovascularization in mice
    Tomita, Yohei
    Cakir, Bertan
    Liu, Chi-Hsiu
    Fu, Zhongjie
    Huang, Shuo
    Cho, Steve S.
    Britton, William R.
    Sun, Ye
    Puder, Mark
    Hellstrom, Ann
    Talukdar, Saswata
    Smith, Lois E. H.
    ANGIOGENESIS, 2020, 23 (03) : 385 - 394
  • [6] Norisoboldine exerts antiallergic effects on IgE/ovalbumin-induced allergic asthma and attenuates FcεRI-mediated mast cell activation
    Chang, Jer-Hwa
    Chuang, Hsiao-Chi
    Fan, Chia-Kwung
    Hou, Tsung-Yun
    Chang, Yu -Cheng
    Lee, Yueh-Lun
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2023, 121
  • [7] Activation of Free Fatty Acid Receptor 4 Affects Intestinal Inflammation and Improves Colon Permeability in Mice
    Salaga, Maciej
    Bartoszek, Adrian
    Binienda, Agata
    Krajewska, Julia B.
    Fabisiak, Adam
    Mosinska, Paula
    Dziedziczak, Katarzyna
    Niewinna, Karolina
    Talar, Marcin
    Tarasiuk, Aleksandra
    Kordek, Radzislaw
    Fichna, Jakub
    NUTRIENTS, 2021, 13 (08)
  • [8] Bee venom ameliorates ovalbumin induced allergic asthma via modulating CD4+CD25+ regulatory T cells in mice
    Choi, Myoung Suk
    Park, Soojin
    Choi, Taewon
    Lee, Gihyun
    Haam, Kyoung-Keun
    Hong, Moo-Chang
    Min, Byung-Il
    Bae, Hyunsu
    CYTOKINE, 2013, 61 (01) : 256 - 265
  • [9] FoxO4 mediates macrophage M2 polarization by promoting LXA4R expression in an ovalbumin-induced allergic asthma model in mice
    Yu, Tong
    Yu, Yiping
    Ma, Yingyu
    Chen, Guoqing
    ALLERGOLOGIA ET IMMUNOPATHOLOGIA, 2023, 51 (04) : 19 - 30
  • [10] Ceramide Synthase 2 Null Mice Are Protected from Ovalbumin-Induced Asthma with Higher T Cell Receptor Signal Strength in CD4+T Cells
    Shin, Sun-Hye
    Cho, Kyung-Ah
    Yoon, Hee-Soo
    Kim, So-Yeon
    Kim, Hee-Yeon
    Pewzner-Jung, Yael
    Jung, Sung-Ae
    Park, Woo-Jae
    Futerman, Anthony H.
    Park, Joo-Won
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (05) : 1 - 18